| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,425 | 845 | 1,698 | 2,326 | | Cost of Revenue | 1,697 | 585 | 1,196 | 1,705 | | | Gross Profit | 728 | 260 | 502 | 620 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 659 | 582 | 725 | 563 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
| 177 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 69 | (322) | (223) | (120) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 0 | 0 | | Earnings Before Interest And Taxes | 69 | (322) | (223) | (120) | | Interest Expense | 68 | 54 | 77 | 142 | | Income Before Tax | 1 | (376) | (299) | (262) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1 | (376) | (299) | (262) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1 | (376) | (299) | (262) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1 | ($376) | ($299) | ($262) |
|
0.51% Nasdaq 
0.0006 (5.71%) 
Income Statement
